Ascent Industries price to free cash flow ACNT

Market value divided by free cash flow over the last twelve months, since 2014.

Today, Oct 23, 2026: n/m; not a meaningful number
Last meaningful: 25.3×; Feb 2026
10-year median: 7.9×
10-year range: 2.8× to 200×
Peer median: 7.8×

Ascent Industries' price to free cash flow is not a meaningful number today: free cash flow over the last twelve months was zero, negative or not reported.

It was last meaningful in Feb 2026, at 25.3×.

On the days it had one over the last ten years, its median was 7.9×, from 2.8× in Apr 2020 to 200× in Apr 2023.

Price to free cash flow over time

median 7.9×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	25.3×	23.7×	26.2×
2025	23.5×	9.1×	23.5×
2024	19.3×	4.6×	20.5×
2023	4.4×	3.4×	200×
2022	11.1×	5.6×	13.1×
2021	5.8×	4.7×	7.3×
2020	5.8×	2.8×	22.2×
2019	22.7×	20.0×	22.7×
2018	n/m a value too high to mean anything
2017	27.3×	27.3×	32.8×
2016	29.2×	3.9×	39.5×
2015	28.3×	5.4×	52.5×
2014	13.0×	12.0×	14.2×

Against its peers

Companies in Chemicals nearest Ascent Industries' size, closest first, today.

Company	Price to free cash flow
ACNTAscent Industries	n/m
NAGENiagen Bioscience	n/m
FTLFFitlife Brands	7.8×
BTMDbiote	1.9×
FTKFlotek Industries	n/m
CRONCronos	24.8×
Peer median	7.8×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Ascent Industries

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.